Cargando…

The fluid membrane determines mechanics of erythrocyte extracellular vesicles and is softened in hereditary spherocytosis

Extracellular vesicles (EVs) are widely studied regarding their role in cell-to-cell communication and disease, as well as for applications as biomarkers or drug delivery vehicles. EVs contain membrane and intraluminal proteins, affecting their structure and thereby likely their functioning. Here, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vorselen, Daan, van Dommelen, Susan M., Sorkin, Raya, Piontek, Melissa C., Schiller, Jürgen, Döpp, Sander T., Kooijmans, Sander A. A., van Oirschot, Brigitte A., Versluijs, Birgitta A., Bierings, Marc B., van Wijk, Richard, Schiffelers, Raymond M., Wuite, Gijs J. L., Roos, Wouter H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251882/ https://www.ncbi.nlm.nih.gov/pubmed/30470753 http://dx.doi.org/10.1038/s41467-018-07445-x

Ejemplares similares

Mechanical Characterization of Liposomes and Extracellular Vesicles, a Protocol
por: Vorselen, Daan, et al.
Publicado: (2020)

The Complexity of Genotype-Phenotype Correlations in Hereditary Spherocytosis: A Cohort of 95 Patients: Genotype-Phenotype Correlation in Hereditary Spherocytosis
por: van Vuren, Annelies, et al.
Publicado: (2019)

Exosome mimetics: a novel class of drug delivery systems
por: Kooijmans, Sander AA, et al.
Publicado: (2012)

Controlled tip wear on high roughness surfaces yields gradual broadening and rounding of cantilever tips
por: Vorselen, Daan, et al.
Publicado: (2016)

Competition between Bending and Internal Pressure Governs the Mechanics of Fluid Nanovesicles
por: Vorselen, Daan, et al.
Publicado: (2017)

P1500: WHAT’S DRIVING RDW? IN-VITRO AND IN-SILICO EVIDENCE FOR OXIDATIVE STRESS
por: Joosse, Huibert-Jan, et al.
Publicado: (2023)

In-vitro and in-silico evidence for oxidative stress as drivers for RDW
por: Joosse, Huibert-Jan, et al.
Publicado: (2023)

Density, heterogeneity and deformability of red cells as markers of clinical severity in hereditary spherocytosis
por: Huisjes, Rick, et al.
Publicado: (2020)

Ektacytometry Analysis of Post-splenectomy Red Blood Cell Properties Identifies Cell Membrane Stability Test as a Novel Biomarker of Membrane Health in Hereditary Spherocytosis
por: Berrevoets, M. C., et al.
Publicado: (2021)

Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting
por: Kooijmans, Sander A. A., et al.
Publicado: (2016)

Hereditary Spherocytosis
por: Huq, Sayeeda, et al.
Publicado: (2010)

Recombinant phosphatidylserine-binding nanobodies for targeting of extracellular vesicles to tumor cells: a plug-and-play approach
por: Kooijmans, Sander A. A., et al.
Publicado: (2018)

Metabolic Fingerprint in Hereditary Spherocytosis Correlates With Red Blood Cell Characteristics and Clinical Severity
por: van Dooijeweert, Birgit, et al.
Publicado: (2021)

Dynamics of phagocytosis mediated by phosphatidylserine
por: Vorselen, Daan
Publicado: (2022)

Splenectomy improves erythrocyte functionality in spherocytosis based on septin abundance, but not maturation defects
por: Cloos, Anne-Sophie, et al.
Publicado: (2023)

Abnormalities of erythrocyte membrane proteins in Korean patients with hereditary spherocytosis.
por: Lee, Y. K., et al.
Publicado: (2000)

Alba shapes the archaeal genome using a delicate balance of bridging and stiffening the DNA
por: Laurens, Niels, et al.
Publicado: (2012)

Hereditary spherocytosis and allied disorders
por: Russo, Roberta, et al.
Publicado: (2019)

Acquired spherocytosis in the setting of myelodysplasia
por: Karlsson, Linda Katharina, et al.
Publicado: (2022)

The Spectrum of SPTA1-Associated Hereditary Spherocytosis
por: Chonat, Satheesh, et al.
Publicado: (2019)

Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients
por: Rab, Minke A.E., et al.
Publicado: (2019)

Extramedullary paraspinal hematopoiesis in hereditary spherocytosis
por: Gogia, P., et al.
Publicado: (2008)

Hereditary spherocytosis: Consequences of delayed diagnosis
por: Steward, Sarah C, et al.
Publicado: (2014)

Paravertebral pseudotumor in patient with hereditary spherocytosis
por: Rabelo, Lêda Maria, et al.
Publicado: (2016)

Cryohemolysis, erythrocyte osmotic fragility, and supplementary hematimetric indices in the diagnosis of hereditary spherocytosis
por: Emilse, Ledesma Achem Miryam, et al.
Publicado: (2018)

Corrigendum: The Spectrum of SPTA1-Associated Hereditary Spherocytosis
por: Chonat, Satheesh, et al.
Publicado: (2019)

Water Softening
Publicado: (1911)

Softening of the Brain
Publicado: (1877)

Softening of the Brain
Publicado: (1859)

Bone-softening
por: Hoge, M. D.
Publicado: (1896)

Softening of the Brain
Publicado: (1871)

Softening of the Brain
Publicado: (1880)

Softening of the Brain
Publicado: (1878)

Drug Delivery with Extracellular Vesicles: From Imagination to Innovation
por: de Jong, Olivier G., et al.
Publicado: (2019)

Anaesthetic management of a case of hereditary spherocytosis for splenectomy and cholecystectomy
por: Chaithanya, Krishna, et al.
Publicado: (2014)

Subtotal Splenectomy in Hereditary Spherocytosis - Advantages and Disadvantages
por: BICĂ, C., et al.
Publicado: (2016)

The diagnostic protocol for hereditary spherocytosis‐2021 update
por: Wu, Yangyang, et al.
Publicado: (2021)

Genotype-degree of hemolysis correlation in hereditary spherocytosis
por: Shi, Yimeng, et al.
Publicado: (2023)

P1527: NEXT GENERATION SEQUENCING IN HEREDITARY SPHEROCYTOSIS DIAGNOSIS
por: García Feria, A., et al.
Publicado: (2022)

Clofarabine-fludarabine-busulfan in HCT for pediatric leukemia: an effective, low toxicity, TBI-free conditioning regimen
por: Versluijs, A. Birgitta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eae740a10kmb7b0vm9u075ksq1